Patients with cancer and a weakened immune system who are treated with immunotherapies tend to fare far worse from COVID-19 than those who haven’t received such therapies in the three months before their COVID diagnosis, show findings in a new study by researchers at Dana-Farber Cancer Institute, and across the U.S., Canada, and Mexico. Researchers found worse outcomes in both the disease itself as well as the fierce immune response that sometimes accompanies it.
Tag: covid 19 and cancer
Cancer Patients Treated with Immunotherapy Can Safely Receive mRNA COVID-19 Vaccines, According to JNCCN Study
New research published in the October 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms the safety of mRNA vaccines in people with cancer undergoing immunotherapy treatment.
NCCN Updates Recommendations for COVID-19 Vaccination with Information on Bivalent Vaccines, Children with Cancer, and Other Developments
National Comprehensive Cancer Network Advisory Committee on COVID-19 Vaccination and Pre-exposure Prophylaxis details clarified expert consensus to help guide providers on latest data and information, available at NCCN.org/covid-19.
COVID-19 in children with cancer: Severe disease and disrupted treatment
Scientists from St. Jude Children’s Research Hospital and the International Society of Paediatric Oncology report results from the Global Registry of COVID-19 and Childhood Cancer.
Cancer Guidelines Organization Supports Mandatory COVID-19 Vaccination for Health Workers
National Comprehensive Cancer Network (NCCN) COVID-19 Vaccination Advisory Committee calls for healthcare workforce vaccine requirements to assure healthcare community is doing all it can to prevent exposure to COVID-19.
Study of Cancer Patients and COVID-19 Highlights Health Disparities
Findings from a study led by researchers at Henry Ford Cancer Institute, in collaboration with Advocate Aurora Health, the Food and Drug Administration and Syapse®, show an elevated risk for severe COVID-19 effects or death among patients with cancer, with the highest risk being among low-income and Black patients.
NCCN Cancer Experts Answer Questions about COVID-19 Vaccines
National Comprehensive Cancer Network’s patient information team provides a patient and caregiver version of recently-updated, evidence-based expert consensus recommendations for vaccinating people with cancer against COVID-19.
Cancer Organizations Urge Priority Access to COVID-19 Vaccine for Cancer Patients, Survivors
130 cancer centers and other cancer organizations sent a letter to President Joseph R. Biden, key members of his administration, and leading state public health officials to strongly encourage prioritizing patients with cancer and survivors of cancer when administering lifesaving COVID-19 vaccines.
NCCN Shares New Guidance Principles for Vaccinating People with Cancer Against COVID-19
The National Comprehensive Cancer Network put out new guidance for COVID-19 vaccinations in people with cancer, based on available evidence plus consensus from top hematology and oncology experts with particular expertise in infectious diseases, vaccine development and delivery, and medical ethics.
AACI Partners With Federal Vaccine Panel to Promote Cancer Patient Health
AACI was invited last summer to join the Vaccine Consultation Panel (VCP) alongside other leading health and science organizations in the U.S. Through the VCP, AACI has received periodic updates on the development and distribution of COVID-19 vaccines and participated in efforts to educate the cancer center community and the general public on the importance of widespread vaccine uptake.
AACI Applauds Approval of COVID-19 Vaccine, Supports Widespread Vaccination Efforts
The Association of American Cancer Institutes (AACI) commends the U.S. Food and Drug Administration (FDA) for its swift action to grant Emergency Use Authorization (EUA) to Pfizer’s COVID-19 vaccine.
Newly diagnosed cancer patients, African Americans more at risk for COVID-19 infection
Cancer patients, especially newly diagnosed and African American patients, are significantly at risk for COVID-19 infection, hospitalization and mortality, according to a new study published in JAMA Oncology by researchers from Case Western Reserve University School of Medicine and the Case Comprehensive Cancer Center.
AACI Urges President Trump to Share Key COVID-19 Information With Biden Transition Team
In a November 20 letter, the Association of American Cancer Institutes (AACI) called on the Trump administration to share vital information about its coronavirus response with President-elect Joe Biden and his transition team.
Dana-Farber Cancer Institute and Quest Diagnostics collaborate to identify the prevalence of COVID-19 in individuals with precursor to multiple myeloma
Dana-Farber Cancer Institute, one of the world’s leading centers of cancer research and treatment, and Quest Diagnostics, (NYSE: DGX), the world’s leading provider of diagnostic information services, announced the start of a new research study that provides free COVID-19 antibody testing to individuals who are at high risk of developing multiple myeloma.
Cancer treatment could be replicated for COVID-19
Beta-blockers could potentially be used to treat COVID-19, according to a new international study by Italian and Australian scientists.
Cedars-Sinai to Study Unequal Impact of COVID-19 on Minorities
Cedars-Sinai has been awarded a five-year, $8.3 million grant by the National Cancer Institute (NCI) to study the diversity and determinants of the immune-inflammatory response to SARS-CoV-2, the virus that causes COVID-19 (coronavirus).
Feeling stressed or down in a world with COVID? Try this writing tool
A new expressive writing tool allows people to put their thoughts and feelings into words to help relieve stress and anxiety. Participants are given a prompt and directed to write for 5-10 minutes, expressing their deepest thoughts and feelings. A computer analyzes keywords and tone to provide feedback.
UCLA joins nationwide clinical trial to study course of COVID-19 in people with cancer
To help better understand the impact and outcomes of COVID-19 in people undergoing cancer treatment, UCLA are participating in a NCI study with cancer centers across the country.
Patient advocate can comment on the intersection of lung cancer and COVID-19
The GO2 Foundation together with other patient advocacy groups, has conducted a survey on the effect of COVID on lung cancer patients and recently participated in an expert panel event with Newswise. Biography :Chief Patient Officer at GO2 Foundation for…
“Take appropriate precautions,” key to protecting lung cancer patients during COVID pandemic, says foundation science director
The GO2 Foundation together with other patient advocacy groups, has conducted a survey on the effect of COVID on lung cancer patients and recently participated in an expert panel event with Newswise. “Now we see the pandemic kind of marching…
Cancer care and screenings must remain a priority during COVID-19
The University of Texas MD Anderson Cancer Center is committed to safely providing patient care and cancer screenings throughout the novel coronavirus (COVID-19) pandemic.
Cancer vs. COVID: When a pandemic upended cancer care
A team of researchers interviewed physicians and patients at the beginning of the COVID-19 pandemic to identify eight scenarios impacting cancer care. Using communication strategies, they created examples of language to help oncologists respond to patients empathetically.
MSK Researchers Find that Common Cancer Treatments Don’t Worsen Coronavirus Infection
A team of researchers at Memorial Sloan Kettering Cancer Center (MSK) reported on the epidemiology of COVID-19 illness experienced at an NCI-designated cancer center during the height of pandemic in New York City.